ePrints
Items where Author is "Liddicoat, J"
 | Up a level |
Group by: Item Type | No Grouping
Number of items: 14.
Article
Aboy, M, Crespo, C, Liddell, K, Liddicoat, J 
ORCID: 0000-0001-7370-3936 and Jordan, M 2018
, 'Was the Myriad decision a 'surgical strike' on isolated DNA patents, or does it have wider impacts?'
, Nature Biotechnology, vol. 36, no. 12
, pp. 1146-1149
, doi: https://doi.org/10.1038/nbt.4308.
ORCID: 0000-0001-7370-3936 and Jordan, M 2018
, 'Was the Myriad decision a 'surgical strike' on isolated DNA patents, or does it have wider impacts?'
, Nature Biotechnology, vol. 36, no. 12
, pp. 1146-1149
, doi: https://doi.org/10.1038/nbt.4308.
Aboy, M, Crespo, C, Liddell, K, Minssen, T and Liddicoat, J ORCID: 0000-0001-7370-3936 2019
, 'Mayo’s impact on patent applications related to biotechnology, diagnostics and personalized medicine'
, Nature Biotechnology, vol. 37, no. 5
, pp. 513-518
, doi: https://doi.org/10.1038/s41587-019-0111-5.
ORCID: 0000-0001-7370-3936 2019
, 'Mayo’s impact on patent applications related to biotechnology, diagnostics and personalized medicine'
, Nature Biotechnology, vol. 37, no. 5
, pp. 513-518
, doi: https://doi.org/10.1038/s41587-019-0111-5.
Aboy, M, Liddell, K, Crespo, C, Cohen, IG, Liddicoat, J ORCID: 0000-0001-7370-3936, Gerke, S and Minssen, T 2019
, 'How does emerging patent case law in the US and Europe affect precision medicine?'
, Nature Biotechnology, vol. 37, no. 10
, pp. 1118-1125
, doi: https://doi.org/10.1038/s41587-019-0265-1.
ORCID: 0000-0001-7370-3936, Gerke, S and Minssen, T 2019
, 'How does emerging patent case law in the US and Europe affect precision medicine?'
, Nature Biotechnology, vol. 37, no. 10
, pp. 1118-1125
, doi: https://doi.org/10.1038/s41587-019-0265-1.
Aboy, M, Liddell, K, Crespo, C, Cohen, IG, Liddicoat, J ORCID: 0000-0001-7370-3936, Gerke, S and Minssen, T 2019
, 'How does emerging patent case law in the US and Europe affect precision medicine?'
, Nature Biotechnology, vol. 37, no. 10
, pp. 1118-1125
, doi: https://doi.org/10.1038/s41587-019-0265-1.
ORCID: 0000-0001-7370-3936, Gerke, S and Minssen, T 2019
, 'How does emerging patent case law in the US and Europe affect precision medicine?'
, Nature Biotechnology, vol. 37, no. 10
, pp. 1118-1125
, doi: https://doi.org/10.1038/s41587-019-0265-1.
Jordan, M, Liddicoat, J ORCID: 0000-0001-7370-3936 and Liddell, K 2021
, 'An empirical study of large, human biobanks: intellectual property policies and financial conditions for access'
, Journal of Law and the Biosciences, vol. 8, no. 1
, pp. 1-32
, doi: https://doi.org/10.1093/jlb/lsab018.
ORCID: 0000-0001-7370-3936 and Liddell, K 2021
, 'An empirical study of large, human biobanks: intellectual property policies and financial conditions for access'
, Journal of Law and the Biosciences, vol. 8, no. 1
, pp. 1-32
, doi: https://doi.org/10.1093/jlb/lsab018.
Jordan, M, Liddicoat, J ORCID: 0000-0001-7370-3936 and Liddell, K 2021
, 'An empirical study of large, human biobanks: intellectual property policies and financial conditions for access'
, Journal of Law and the Biosciences, vol. 8, no. 1
, pp. 1-32
, doi: https://doi.org/10.1093/jlb/lsab018.
ORCID: 0000-0001-7370-3936 and Liddell, K 2021
, 'An empirical study of large, human biobanks: intellectual property policies and financial conditions for access'
, Journal of Law and the Biosciences, vol. 8, no. 1
, pp. 1-32
, doi: https://doi.org/10.1093/jlb/lsab018.
Liddicoat, J ORCID: 0000-0001-7370-3936 2017
, 'Standing on the edge - what type of 'exclusive licensees' should be able to initiate patent infringement actions?'
, International Review of Intellectual Property and Competition Law, vol. 48
, pp. 626-651
, doi: https://doi.org/10.1007/s40319-017-0620-z.
ORCID: 0000-0001-7370-3936 2017
, 'Standing on the edge - what type of 'exclusive licensees' should be able to initiate patent infringement actions?'
, International Review of Intellectual Property and Competition Law, vol. 48
, pp. 626-651
, doi: https://doi.org/10.1007/s40319-017-0620-z.
Liddicoat, J ORCID: 0000-0001-7370-3936 2017
, 'Standing on the edge - what type of 'exclusive licensees' should be able to initiate patent infringement actions?'
, International Review of Intellectual Property and Competition Law, vol. 48
, pp. 626-651
, doi: https://doi.org/10.1007/s40319-017-0620-z.
ORCID: 0000-0001-7370-3936 2017
, 'Standing on the edge - what type of 'exclusive licensees' should be able to initiate patent infringement actions?'
, International Review of Intellectual Property and Competition Law, vol. 48
, pp. 626-651
, doi: https://doi.org/10.1007/s40319-017-0620-z.
Liddicoat, J ORCID: 0000-0001-7370-3936, Liddell, K and Aboy, M 2019
, 'The effects of Myriad and Mayo on molecular test development in the US and Europe: interviews from the Frontline'
, Vanderbilt Journal of Entertainment & Technology Law, vol. 22, no. 4
, pp. 785-837
, doi: https://doi.org/10.2139/ssrn.3381553.
ORCID: 0000-0001-7370-3936, Liddell, K and Aboy, M 2019
, 'The effects of Myriad and Mayo on molecular test development in the US and Europe: interviews from the Frontline'
, Vanderbilt Journal of Entertainment & Technology Law, vol. 22, no. 4
, pp. 785-837
, doi: https://doi.org/10.2139/ssrn.3381553.
Liddicoat, J ORCID: 0000-0001-7370-3936, Liddell, K, Aboy, M and Wested, J 2021
, 'Has the EU incentive for drug repositioning been effective? An empirical analysis of the “+1” regulatory exclusivity'
, IIC - International Review of Intellectual Property and Competition Law, vol. 52
, pp. 825-851
, doi: https://doi.org/10.17863/CAM.68712.
ORCID: 0000-0001-7370-3936, Liddell, K, Aboy, M and Wested, J 2021
, 'Has the EU incentive for drug repositioning been effective? An empirical analysis of the “+1” regulatory exclusivity'
, IIC - International Review of Intellectual Property and Competition Law, vol. 52
, pp. 825-851
, doi: https://doi.org/10.17863/CAM.68712.
Liddicoat, J ORCID: 0000-0001-7370-3936, Liddell, K, Aboy, M and Wested, J 2021
, 'Has the EU incentive for drug repositioning been effective? An empirical analysis of the “+1” regulatory exclusivity'
, IIC - International Review of Intellectual Property and Competition Law, vol. 52, no. 7
, pp. 825-851
, doi: https://doi.org/10.17863/CAM.68712.
ORCID: 0000-0001-7370-3936, Liddell, K, Aboy, M and Wested, J 2021
, 'Has the EU incentive for drug repositioning been effective? An empirical analysis of the “+1” regulatory exclusivity'
, IIC - International Review of Intellectual Property and Competition Law, vol. 52, no. 7
, pp. 825-851
, doi: https://doi.org/10.17863/CAM.68712.
Nicol, D ORCID: 0000-0002-6553-2839, Dreyfuss, RC, Gold, ER, Li, W, Liddicoat, J ORCID: 0000-0001-7370-3936 and Van Overwalle, G 2019
, 'International divergence in gene patenting'
, Annual Review of Genomics and Human Genetics, vol. 20, no. 1
, pp. 519-541
, doi: https://doi.org/10.1146/annurev-genom-083118-015112.
ORCID: 0000-0002-6553-2839, Dreyfuss, RC, Gold, ER, Li, W, Liddicoat, J ORCID: 0000-0001-7370-3936 and Van Overwalle, G 2019
, 'International divergence in gene patenting'
, Annual Review of Genomics and Human Genetics, vol. 20, no. 1
, pp. 519-541
, doi: https://doi.org/10.1146/annurev-genom-083118-015112.
Nicol, D ORCID: 0000-0002-6553-2839, Dreyfuss, RC, Gold, ER, Li, W, Liddicoat, J ORCID: 0000-0001-7370-3936 and Van Overwalle, G 2019
, 'International divergence in gene patenting'
, Annual Review of Genomics and Human Genetics, vol. 20, no. 1
, pp. 519-541
, doi: https://doi.org/10.1146/annurev-genom-083118-015112.
ORCID: 0000-0002-6553-2839, Dreyfuss, RC, Gold, ER, Li, W, Liddicoat, J ORCID: 0000-0001-7370-3936 and Van Overwalle, G 2019
, 'International divergence in gene patenting'
, Annual Review of Genomics and Human Genetics, vol. 20, no. 1
, pp. 519-541
, doi: https://doi.org/10.1146/annurev-genom-083118-015112.
Nicol, D ORCID: 0000-0002-6553-2839, Eckstein, L ORCID: 0000-0002-7161-7521, Morrison, M, Sherkow, JS, Otlowski, M ORCID: 0000-0003-4707-4325, Whitton, T, Bubela, T, Burdon, KP ORCID: 0000-0001-8217-1249, Chalmers, D ORCID: 0000-0002-7925-8818, Chan, S, Charlesworth, J ORCID: 0000-0001-6201-3518, Critchley, C, Crossley, M, de Lacey, S, Dickinson, JL ORCID: 0000-0003-4621-1703, Hewitt, AW ORCID: 0000-0002-5123-5999, Kamens, J, Kato, K, Kleiderman, E, Kodama, S, Liddicoat, J, Mackey, DA, Newson, AJ, Nielsen, J ORCID: 0000-0002-3005-0047, Wagner, JK and McWhirter, RE ORCID: 0000-0002-9409-8074 2017
, 'Key challenges in bringing CRISPR-mediated somatic cell therapy into the clinic'
, Genome Medicine, vol. 9, no. 1
, pp. 1-4
, doi: https://doi.org/10.1186/s13073-017-0475-4.
ORCID: 0000-0002-6553-2839, Eckstein, L ORCID: 0000-0002-7161-7521, Morrison, M, Sherkow, JS, Otlowski, M ORCID: 0000-0003-4707-4325, Whitton, T, Bubela, T, Burdon, KP ORCID: 0000-0001-8217-1249, Chalmers, D ORCID: 0000-0002-7925-8818, Chan, S, Charlesworth, J ORCID: 0000-0001-6201-3518, Critchley, C, Crossley, M, de Lacey, S, Dickinson, JL ORCID: 0000-0003-4621-1703, Hewitt, AW ORCID: 0000-0002-5123-5999, Kamens, J, Kato, K, Kleiderman, E, Kodama, S, Liddicoat, J, Mackey, DA, Newson, AJ, Nielsen, J ORCID: 0000-0002-3005-0047, Wagner, JK and McWhirter, RE ORCID: 0000-0002-9409-8074 2017
, 'Key challenges in bringing CRISPR-mediated somatic cell therapy into the clinic'
, Genome Medicine, vol. 9, no. 1
, pp. 1-4
, doi: https://doi.org/10.1186/s13073-017-0475-4.